The Stop TB Partnership’s Global Drug Facility (GDF) has expanded its Diagnostics Catalog by adding an IGRA (interferon-gamma release assay) test for latent TB infection. The products required to run the QuantiFERON-TB Gold Plus (QFT-Plus) IGRA are now available at a GDF-negotiated price of $15.90 per test by the manufacturer Qiagen (Hilden, Germany). This price is offered to any public sector or not-for-profit buyer in low- and middle-income countries when procuring through GDF.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
Use of alternative interferon-gamma release assays for the diagnosis of TB infection - WHO Policy Statement | 0 | 533 | January 28, 2022 | |
Fourth generation QuantiFERON-TB Gold-Plus: What is the evidence? | 0 | 415 | June 4, 2020 | |
Stop TB Partnership GDF, Eiken and HUMAN collaboration leads to TB-LAMP reaching target price of US$6 | 0 | 341 | March 2, 2020 | |
FluoroType MTBDR VER 2.0 available in Stop TB Partnership's GDF catalog | 0 | 153 | January 25, 2024 | |
Global Fund, USAID and Stop TB Partnership's New Collaboration With Molbio Diagnostics Will Increase Access to Rapid Molecular Tests for TB | 0 | 290 | March 10, 2023 |